Published in Sci Rep on March 04, 2014
Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions. J Am Chem Soc (2014) 0.86
Comparisons with amyloid-β reveal an aspartate residue that stabilizes fibrils of the aortic amyloid peptide medin. J Biol Chem (2015) 0.84
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology. J Diabetes Res (2015) 0.83
Fiber-dependent and -independent toxicity of islet amyloid polypeptide. Biophys J (2014) 0.82
Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics. Elife (2016) 0.78
Extension of the generic amyloid hypothesis to nonproteinaceous metabolite assemblies. Sci Adv (2015) 0.77
Foldamer-mediated manipulation of a pre-amyloid toxin. Nat Commun (2016) 0.77
Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption. J Biol Chem (2015) 0.77
Use of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin Secretion. PLoS One (2015) 0.76
Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis. J Diabetes Res (2015) 0.76
Cytotoxic helix-rich oligomer formation by melittin and pancreatic polypeptide. PLoS One (2015) 0.76
The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes. Sci Rep (2017) 0.75
Identification of Plant Extracts that Inhibit the Formation of Diabetes-Linked IAPP Amyloid. J Herb Med (2016) 0.75
Multi‑transgenic minipig models exhibiting potential for hepatic insulin resistance and pancreatic apoptosis. Mol Med Rep (2015) 0.75
On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides. J Diabetes Res (2015) 0.75
Foldamer scaffolds suggest distinct structures are associated with alternative gains-of-function in a preamyloid toxin. Chem Commun (Camb) (2016) 0.75
Atomic structures of fibrillar segments of hIAPP suggest tightly mated β-sheets are important for cytotoxicity. Elife (2017) 0.75
Facet-Dependent Interactions of Islet Amyloid Polypeptide with Gold Nanoparticles: Implications for Fibril Formation and Peptide-Induced Lipid Membrane Disruption. Chem Mater (2017) 0.75
Novel insight into streptozotocin-induced diabetic rats from the protein misfolding perspective. Sci Rep (2017) 0.75
Understanding co-polymerization in amyloid formation by direct observation of mixed oligomers. Chem Sci (2017) 0.75
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol (2010) 6.64
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A (2000) 5.83
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem (2002) 5.63
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat Med (1998) 5.49
Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature (2002) 5.32
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A (1987) 4.53
The amyloid state of proteins in human diseases. Cell (2012) 4.53
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem (2005) 4.23
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature (1994) 3.95
Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A (2005) 3.91
The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes (1999) 3.30
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A (1990) 3.29
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia (1978) 2.31
Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry (2002) 2.29
A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun (1986) 2.24
Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist (1997) 2.06
Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem (2008) 2.04
Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem (1996) 2.01
Role of IL-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes (2010) 1.97
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A (1996) 1.81
Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem (2004) 1.79
Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J Biol Chem (2008) 1.76
Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann Neurol (2009) 1.65
Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol (1987) 1.60
Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J Am Chem Soc (2008) 1.56
Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry (2008) 1.47
Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A (1988) 1.47
Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci (2009) 1.46
Fine structure of islets of Langerhans in insular amyloidosis. Virchows Arch A Pathol Pathol Anat (1973) 1.45
Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients. Diabetologia (1998) 1.44
The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A (1973) 1.43
Hyalinization of the islets of Langerhans in nondiabetic individuals. Am J Pathol (1959) 1.41
Dynamic alpha-helix structure of micelle-bound human amylin. J Biol Chem (2009) 1.36
Structural polymorphism of Alzheimer Abeta and other amyloid fibrils. Prion (2009) 1.35
Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. Biophys J (2012) 1.31
Autoantibodies to alpha-synuclein in inherited Parkinson's disease. J Neurochem (2007) 1.22
Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim Biophys Acta (2011) 1.20
S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol (2000) 1.18
α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients. PLoS One (2011) 1.18
Common mechanism unites membrane poration by amyloid and antimicrobial peptides. Proc Natl Acad Sci U S A (2013) 1.16
Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J (2011) 1.14
Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromolecular Med (2007) 1.12
Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia (1987) 1.10
Immunohistology of islet amyloid polypeptide in diabetes mellitus: semi-quantitative studies in a post-mortem series. Virchows Arch A Pathol Anat Histopathol (1992) 1.01
Visualization of co-localization in Aβ42-administered neuroblastoma cells reveals lysosome damage and autophagosome accumulation related to cell death. Biochem J (2012) 0.97
Mast cells in the islets of Langerhans in insular amyloidosis. Virchows Arch A Pathol Pathol Anat (1971) 0.79
The molecular significance of amyloid beta-peptide for Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci (1996) 0.79